A multi-centre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of ART621 following multiple dose administration for 3 months in patients with rheumatoid arthritis concomitantly taking methotrexate.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Placulumab; Placulumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Arana Therapeutics
- 31 Aug 2018 Biomarkers information updated
- 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India, CTRI2009-091-000569).
- 07 Jan 2010 Actual patient number (13) added as reported by ClinicalTrials.gov.